ABOUT STRUCTURAL HEART

BUILT FOR BETTER LIFE

We partner with some of the world's best specialists and care teams that we know, to repair the damage caused by structural heart diseases and help rebuild healthier hearts—through better therapies, better evidence, and better experience. It’s that simple.

We’re leading the way for structural heart therapies and challenging current treatment options to change the course of patient care.1

  • Read more

    Our comprehensive portfolio is designed to be as minimally invasive as possible and to treat a broad range of patients with structural heart diseases, from infants to elderly patients. We’ve set a new standard of care as we relentlessly focus on delivering better solutions to more patients.

Our clinical trials provide proof that inspires confidence for physicians and patients.1

  • Read more

    With successful clinical results from tens of thousands of patients across the structural heart portfolio and over 45 active clinical trials, we continue to go above and beyond as we grow the body of evidence for our structural heart devices. Our legacy of leadership and expertise back us as we build better therapies for the growing number of structural heart patients.

We’re dedicated to helping care teams deliver the full potential of every structural heart procedure, from procedural training and imaging expertise to proctorship support and beyond.1

  • Read more

    Our patient-first focus means we prioritize maximizing benefits and minimizing risk for all patients, so physicians can help them reclaim their quality of life. We build deep, trusted partnerships with healthcare providers to ensure that everyone and everything beats as one.

THE AGING GLOBAL POPULATION HAS INTENSIFIED THE BURDEN OF STRUCTURAL HEART DISEASE

 

1.6 BILLION
PEOPLE AGED 60 OR OLDER
BY 20302

 

1 in 10 PEOPLE
OVER 65 YEARS OLD HAVE
MODERATE OR
SEVERE VALVE DISEASE3

 

#1 CAUSE OF DEATH
HEART DISEASE REMAINS
NO. 1 CAUSE OF DEATH4

Explore the interactive heart model below to learn more about our products and solutions across the structural heart spectrum.

Mitral Regurgitation

A condition in which the mitral valve does not close completely during contraction of the left ventricle, causing blood to leak backward into the left atrium.
Click on a product name to learn more about our therapy solutions
  • MitraClipTM Therapy

    MitraClipTM Therapy is a minimally invasive TMVr therapy that delivers a treatment option for select patients with mitral regurgitation who would otherwise go untreated.*
    *TMVr is also referred to as (Transcatheter edge-to-edge repair)
    MitraClip Therapy
    Learn More
  • EpicTM Mitral Stented Tissue Valve

    The EpicTM Mitral stented tissue valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic mitral heart valve.
    Epic™ Mitral Stented Tissue Valve
    Learn More
  • TendyneTM TMVR

    TendyneTM Transcatheter Mitral Valve Replacement offers select patients who have symptomatic, significant mitral regurgitation (≥ grade 3), a new option for safe and effective valve replacement.
    Tendyne™ TMVI
    Learn More
EpicTM MitralMitraClipTMTendyneTM
×

Aortic Stenosis

A narrowing of the aortic valve, which reduces or blocks blood flow from the left ventricle to the aorta.
Click on a product name to learn more about our therapy solutions
  • PorticoTM Valve

    The PorticoTM with FlexNavTM TAVI system is a minimally invasive treatment for patients with aortic stenosis.
    Abbott Portico with FlexNav TAVI system
    Learn More
  • EpicTM Supra Stented Tissue Valve

    The EpicTM Supra stented tissue valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve.
    Epic Supra stented tissue valve
    Learn More
  • RegentTM MHV

    The RegentTM mechanical heart valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic valve.
    Regent MHV
    Learn More
  • TrifectaTM GT Valve

    The TrifectaTM Valve with GlideTM Technology (GT) is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve.
    Trifecta GT Valve
    Learn More
PorticoTMEpicTM SupraRegentTMTrifectaTM GT
×

Stroke Risk Reduction

Interventions intended to prevent thrombus formation include percutaneous closure of the left atrial appendage (LAA) and the patent foramen ovale (PFO).
Click on a product name to learn more about our therapy solutions
  • AmplatzerTM AmuletTM LAA Occluder

    A percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in suitable patients with nonvalvular atrial fibrillation.
    Amplatzer Amulet occluder for atrial fibrillation
    Learn More
  • AmplatzerTM TalismanTM PFO Occluder

    Designed for patent foramen ovale (PFO) closure, the AmplatzerTM TalismanTM PFO Occluder reduces the risk of recurrent ischemic stroke.
    Amplatzer™ Talisman™ PFO occluder
    Learn More
AmplatzerTM AmuletTM LAA OccluderAmplatzerTM TalismanTM PFO Occluder
×

Congenital defects

Congenital heart defects can involve the walls of the heart, the heart valves, and arteries and veins near the heart, disrupting normal blood flow.
Click on a product name to learn more about our therapy solutions
  • AmplatzerTM Septal Occluder

    A percutaneous transcatheter device for patients requiring atrial septal defect (ASD) closure.
    Amplatzer Septal occluder
    Learn More
  • AmplatzerTM VSD Occluder

    Ventricular septal defects (VSDs) are the most common congenital heart defect, and AmplatzerTM Muscular VSD Occluders provide minimally invasive treatment options.
    Amplatzer VSD occluder
    Learn More
AmplatzerTM Septal OccluderAmplatzerTM VSD Occluder
×

Tricuspid Regurgitation

A condition in which the tricuspid valve’s leaflets (or flaps) do not close properly, causing blood to flow backward into the right atrium.
Click on a product name to learn more about our therapy solutions
  • TriClipTM Therapy

    TriClipTM Transcatheter Edge-to-Edge Repair is a minimally invasive, non-surgical treatment option for severe, symptomatic tricuspid regurgitation patients who are at a high risk for surgery.
    TriClip™
    Learn More
TriClipTM
×
MAT-2200917 v2.0 | Item approved for OUS use only.

PARTNERING IN EXCELLENCE

We partner with healthcare providers to deliver unwavering training and support, lending our clinical insights into patient selection, echocardiography and diagnostics, device therapies, and procedural details. All to help physicians deliver the full potential of every Abbott technology.

CONTACT US TO LEARN MORE

 

PARTNERING IN EXCELLENCE

We partner with healthcare providers to deliver unwavering training and support, lending our clinical insights into patient selection, echocardiography and diagnostics, device therapies, and procedural details. All to help physicians deliver the full potential of every Abbott technology.

CONTACT US TO LEARN MORE

PROCEDURAL TRAINING

Our team of clinical experts are with your staff for every training procedure, committed to consistent guidance every step of the way.

IMAGING EXPERTISE

As transcatheter valve therapies advance, so do imaging technologies—and with them, the need for a trusted partner. Our proctors are highly trained to support your team’s imaging efforts and have the deep procedural experience to help troubleshoot any scenario.

IMAGING EXPERTISE

As transcatheter valve therapies advance, so do imaging technologies—and with them, the need for a trusted partner. Our proctors are highly trained to support your team’s imaging efforts and have the deep procedural experience to help troubleshoot any scenario.

ONGOING SUPPORT

From the robust initial training new centers undergo, to proctoring and case monitoring, and supplementary training offerings, our support enables your continued growth in efficiency and outcomes from day one and beyond.

MAT-2010285 v.2.0 | Item approved for Global OUS use only.

Copyright © 2022 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v10.0 | Item approved for OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.